Charles River Laboratories International (CRL) Cash from Investing Activities (2009 - 2025)

Charles River Laboratories International's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$92.8 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 21.95% year-over-year to -$92.8 million; the TTM figure through Dec 2025 stood at -$209.3 million (up 14.59% YoY), while the FY2025 annual figure was -$209.3 million, up 14.59% from the prior year.
• Cash from Investing Activities was -$92.8 million for Q4 2025 at Charles River Laboratories International, down from -$33.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $44.4 million in Q4 2022 to a low of -$954.2 million in Q2 2021.
• Historically, Cash from Investing Activities has averaged -$153.2 million across 5 years, with a median of -$82.7 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities sank 3233.31% in 2021, then surged 376.88% in 2022.
• A 5-year view of Cash from Investing Activities shows it stood at $9.3 million in 2021, then soared by 376.88% to $44.4 million in 2022, then tumbled by 637.08% to -$238.4 million in 2023, then soared by 68.07% to -$76.1 million in 2024, then decreased by 21.95% to -$92.8 million in 2025.
• The last three Cash from Investing Activities figures came in at -$92.8 million (Q4 2025), -$33.7 million (Q3 2025), and -$37.3 million (Q2 2025), per Business Quant data.